The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
A more tubulocentric view of diabetic kidney disease
Open accessAbstract
Diabetic nephropathy (DN) is a common complication of Diabetes Mellitus (DM) Types 1 and 2, and prevention of end stage renal disease (ESRD) remains a major challenge. Despite its high prevalence, the pathogenesis of DN is still controversial. Initial glomerular disease manifested by hyperfiltration and loss of glomerular size and charge permselectivity may initiate a cascade of injuries, including tubulo-interstitial disease. Clinically, 'microalbuminuria' is still accepted as an early biomarker of glomerular damage, despite mounting evidence that its predictive value for DN is questionable, and findings that suggest the proximal tubule is an important link in the development of DN. The concept of 'diabetic tubulopathy' has emerged from recent studies, and its causative role in DN is supported by clinical and experimental evidence, as well as plausible pathogenetic mechanisms. This review explores the 'tubulocentric' view of DN. The recent finding that inhibition of proximal tubule (PT) glucose transport (via SGLT2) is nephro-protective in diabetic patients is discussed in relation to the tubule's potential role in DN. Studies with a tubulocentric view of DN have stimulated alternative clinical approaches to the early detection of diabetic kidney disease. There are tubular biomarkers considered as direct indicators of injury of the proximal tubule (PT), such as N-acetyl-β-D-glucosaminidase, Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1, and other functional PT biomarkers, such as Urine free Retinol-Binding Protein 4 and Cystatin C, which reflect impaired reabsorption of filtered proteins. The clinical application of these measurements to diabetic patients will be reviewed in the context of the need for better biomarkers for early DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Biology of Human Sodium Glucose Transporters
Wright, E. M., Loo, D. D. F., & Hirayama, B. A. (2011) · Physiological Reviews · doi:10.1152/physrev.00055.2009 · Cited by 1,430
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
Ferrannini, E., Mark, M., & Mayoux, E. (2016) · Diabetes Care · doi:10.2337/dc16-0330 · Cited by 975
Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887 · cited 21×
“Interestingly, a study exploring the effect of glomerular hyperfiltration on tubular dysfunction reported that two markers of tubular damage (Neutrophil gelatinase-associated lipocalin NGAL and Kidney Injury Molecule-1 KIM-1) showed increased excretion in the urine of those with glomerular hyperfiltration and it corre…”
BackgroundInfluentialUS Renal Data System 2011 Annual Data Report
Collins, A. J., Foley, R. N., Chavers, B., Gilbertson, D., Herzog, C., Johansen, K., Kasiske, B., Kutner, N., Liu, J., St. Peter, W., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.015 · Cited by 820
Understanding the nature of renal disease progression
Remuzzi, G., Ruggenenti, P., & Benigni, A. (1997) · Kidney International · doi:10.1038/ki.1997.2 · Cited by 649
Gilbert, R. E., & Cooper, M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00721.x · Cited by 649
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635 · cited 2×
“Another mechanism that also might contribute to nephro-protection of SGLT2 inhibitors is the increased renal content of HIF1-α [42].”
BackgroundVallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483
Histopathology of Diabetic Nephropathy
Fioretto, P., & Mauer, M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.012 · Cited by 467
Russo, L. M., Sandoval, R. M., McKee, M., Osicka, T. M., Collins, A. B., Brown, D., Molitoris, B. A., & Comper, W. D. (2007) · Kidney International · doi:10.1038/sj.ki.5002041 · Cited by 400
Vallon, V., & Thomson, S. C. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153333 · Cited by 376
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
Vallon, V. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-110046 · Cited by 348
Rieg, T., Masuda, T., Gerasimova, M., Mayoux, E., Platt, K., Powell, D. R., Thomson, S. C., Koepsell, H., & Vallon, V. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00518.2013 · Cited by 310
Low Glomerular Filtration Rate in Normoalbuminuric Type 1 Diabetic Patients
Caramori, M. L., Fioretto, P., & Mauer, M. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1036 · Cited by 301
Perkins, B. A., Ficociello, L. H., Roshan, B., Warram, J. H., & Krolewski, A. S. (2010) · Kidney International · doi:10.1038/ki.2009.399 · Cited by 289
Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
Zürbig, P., Jerums, G., Hovind, P., MacIsaac, R. J., Mischak, H., Nielsen, S. E., Panagiotopoulos, S., Persson, F., & Rossing, P. (2012) · Diabetes · doi:10.2337/db12-0348 · Cited by 266
Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
Russo, L. M., Sandoval, R. M., Campos, S. B., Molitoris, B. A., Comper, W. D., & Brown, D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050503 · Cited by 261
The Proximal Tubule and Albuminuria: Really!
Dickson, L. E., Wagner, M. C., Sandoval, R. M., & Molitoris, B. A. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090950 · Cited by 261
Pathophysiology of the Diabetic Kidney
Vallon, V., & Komers, R. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100049 · Cited by 259
Abdul-Ghani, M. A., DeFronzo, R. A., & Norton, L. (2013) · Diabetes · doi:10.2337/db13-0604 · Cited by 249
Glomerular protein sieving and implications for renal failure in Fanconi syndrome
Norden, A. G. W., Lapsley, M., Lee, P. J., Pusey, C. D., Scheinman, S. J., Tam, F. W. K., Thakker, R. V., Unwin, R. J., & Wrong, O. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00016.x · Cited by 241
Self-citationUrinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients
Delić, D., Eisele, C., Schmid, R., Baum, P., Wiech, F., Gerl, M., Zimdahl, H., Pullen, S. S., & Urquhart, R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150154 · Cited by 228
SGLT2 Inhibition in the Diabetic Kidney—From Mechanisms to Clinical Outcome
van Bommel, E. J. M., Muskiet, M. H. A., Tonneijck, L., Kramer, M. H. H., Nieuwdorp, M., & van Raalte, D. H. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06080616 · Cited by 222
Can We Target Tubular Damage to Prevent Renal Function Decline in Diabetes?
Bonventre, J. V. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.008 · Cited by 219
Time to abandon microalbuminuria?
Ruggenenti, P., & Remuzzi, G. (2006) · Kidney International · doi:10.1038/sj.ki.5001729 · Cited by 213
The pathogenic role of the renal proximal tubular cell in diabetic nephropathy
Tang, S. C. W., & Lai, K. N. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs260 · Cited by 207
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1611290 · Cited by 198
ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
Chen, K., Zhang, J., Zhang, W., Zhang, J., Yang, J., Li, K., & He, Y. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.009 · Cited by 197
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Song, P., Onishi, A., Koepsell, H., & Vallon, V. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1168808 · Cited by 194
The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years
Martínez-Castelao, A., Navarro-González, J., Górriz, J., & De Alvaro, F. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4061207 · Cited by 173
Marks, J., Carvou, N. J. C., Debnam, E. S., Srai, S. K., & Unwin, R. J. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.046268 · Cited by 166
Self-citationUrinary Biomarkers in the Assessment of Early Diabetic Nephropathy
Gluhovschi, C., Gluhovschi, G., Petrica, L., Timar, R., Velciov, S., Ionita, I., Kaycsa, A., & Timar, B. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4626125 · Cited by 161
Improved glycemic control in mice lacking Sglt1 and Sglt2
Powell, D. R., DaCosta, C. M., Gay, J., Ding, Z.-M., Smith, M., Greer, J., Doree, D., Jeter-Jones, S., Mseeh, F., Rodriguez, L. A., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00439.2012 · Cited by 158
Proximal tubular basement membrane width in insulin-dependent diabetes mellitus
Brito, P. L., Fioretto, P., Drummond, K., Kim, Y., Steffes, M. W., Basgen, J. M., Sisson-Ross, S., & Mauer, M. S. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00809.x · Cited by 154
Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats
Tojo, A., Onozato, M. L., Ha, H., et al. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180100317 · Cited by 151
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
Simpson, K., Wonnacott, A., Fraser, D. J., & Bowen, T. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0724-8 · Cited by 146
Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy
Kim, S. S., Song, S. H., Kim, I. J., Jeon, Y. K., Kim, B. H., Kwak, I. S., Lee, E. K., & Kim, Y. K. (2012) · Diabetes Care · doi:10.2337/dc12-0849 · Cited by 139
Liu, W. J., Shen, T. T., Chen, R. H., Wu, H.-L., Wang, Y. J., Deng, J. K., Chen, Q. H., Pan, Q., Huang Fu, C.-M., Tao, J.-L., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.666354 · Cited by 132
Diabetic nephropathy: Traditional to proteomic markers
Moresco, R. N., Sangoi, M. B., de Carvalho, J. A. M., Tatsch, E., & Bochi, G. V. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.019 · Cited by 131
Urinary biomarkers for early diabetic nephropathy: beyond albuminuria
Lee, S., & Choi, M. E. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2888-2 · Cited by 130
Atubular Glomeruli and Glomerulotubular Junction Abnormalities in Diabetic Nephropathy
Najafian, B., Kim, Y., Crosson, J. T., & Mauer, M. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000057854.32413.81 · Cited by 125
Histological changes of kidney in diabetic nephropathy.
Pourghasem, M., Shafi, H., & Babazadeh, Z. (2015) · PubMed Central · Cited by 124
Mise, K., Hoshino, J., Ueno, T., Hazue, R., Hasegawa, J., Sekine, A., Sumida, K., Hiramatsu, R., Hasegawa, E., Yamanouchi, M., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04980515 · Cited by 124
Nephron Protection in Diabetic Kidney Disease
Anders, H., Davis, J. M., & Thurau, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmcibr1608564 · Cited by 124
Diabetic Tubulopathy: An Emerging Entity
Tang, S. C. W., Leung, J. C. K., & Lai, K. N. (2011) · Contributions to nephrology · doi:10.1159/000325647 · Cited by 122
Purinergic signaling in kidney disease
Menzies, R. I., Tam, F. W. K., Unwin, R. J., & Bailey, M. A. (2016) · Kidney International · doi:10.1016/j.kint.2016.08.029 · Cited by 121
Self-citationSodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
Novikov, A., & Vallon, V. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000187 · Cited by 112
Thrailkill, K. M., Nimmo, T., Bunn, R. C., Cockrell, G. E., Moreau, C. S., Mackintosh, S. G., Edmondson, R. D., & Fowlkes, J. L. (2009) · Diabetes Care · doi:10.2337/dc09-0112 · Cited by 107
Panduru, N. M., Forsblom, C. M., Saraheimo, M., Thorn, L. M., Bierhaus, A., Humpert, P. M., Groop, P., & on behalf of the FinnDiane Study Group (2013) · Diabetes Care · doi:10.2337/dc12-1868 · Cited by 106
Kern, E. F. O., Erhard, P., Sun, W., GENUTH, S. M., & Weiss, M. F. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.009 · Cited by 105
Nielsen, S. E., Andersen, S., Zdunek, D., Heß, G., Parving, H., & Rossing, P. R. (2011) · Kidney International · doi:10.1038/ki.2010.554 · Cited by 99
Argyropoulos, C., Wang, K., Bernardo, J., Ellis, D., Orchard, T. J., Galas, D. J., & Johnson, J. P. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4071498 · Cited by 95
Slyne, J., Slattery, C., McMorrow, T., & Ryan, M. P. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv264 · Cited by 94
Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy
Mori, K. P., Yokoi, H., Kasahara, M., Imamaki, H., Ishii, A., Kuwabara, T., Koga, K., Kato, Y. H., Toda, N., Ohno, S., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015101168 · Cited by 79
Glomerulotubular Junction Abnormalities Are Associated with Proteinuria in Type 1 Diabetes
Najafian, B., Crosson, J. T., Kim, Y., & Mauer, M. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121342 · Cited by 72
Proximal Tubules Have the Capacity to Regulate Uptake of Albumin
Wagner, M. C., Campos, S. B., Chowdhury, M., Flores, B. N., Lai, X., Myslinski, J., Pandit, S., Sandoval, R. M., Wean, S. E., Wei, Y., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111107 · Cited by 71
Petrică, L., Vlad, A., Gluhovschi, G., Gădălean, F., Dumitraşcu, V., Gluhovschi, C. A., Velciov, S. M., Bob, F. R., Vlad, M., Popescu, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112538 · Cited by 70
Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration
Fu, W., Li, B.-L., Wang, S., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.031 · Cited by 70
Increased Tubular Proliferation as an Adaptive Response to Glomerular Albuminuria
Guo, J.-K., Marlier, A., Shi, H., Shan, A., Ardito, T. A., Du, Z., Kashgarian, M. J., Krause, D. S., Biemesderfer, D., & Cantley, L. G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040396 · Cited by 69
Conway, B. R., Manoharan, D., Manoharan, D., Jenks, S. J., Dear, J. W., McLachlan, S., Strachan, M. W. J., & Price, J. F. (2012) · Kidney International · doi:10.1038/ki.2012.218 · Cited by 68
Nitric oxide in the normal kidney and in patients with diabetic nephropathy
Tessari, P. (2014) · Journal of Nephrology · doi:10.1007/s40620-014-0136-2 · Cited by 63
Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy
Tramonti, G., & Kanwar, Y. S. (2012) · Endocrine · doi:10.1007/s12020-012-9820-y · Cited by 61
Nephrinuria associates with multiple renal traits in type 2 diabetes
Ng, D. P. K., Tai, B., Tan, E., Leong, H., Yaakub, S. N., Lim, X.-L., Chia, K., Wong, C.-S., Lim, W., & Holthöfer, H. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq738 · Cited by 61
Piscitelli, P. A., Viazzi, F. C., Fioretto, P., Giorda, C. B., Ceriello, A., Genovese, S., Russo, G. T., Guida, P., Pontremoli, R., & Cosmo, S. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-03551-w · Cited by 53
Nielsen, R., Mollet, G., Esquivel, E. L., Weyer, K., Nielsen, P. K., Antignac, C., & Christensen, E. I. (2013) · Kidney International · doi:10.1038/ki.2013.218 · Cited by 52
Saikumar, J., Ramachandran, K., & Vaidya, V. S. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.216044 · Cited by 44
A discovery-phase urine proteomics investigation in type 1 diabetes
Soggiù, A., Piras, C., Bonizzi, L., Hussein, H. A., Pisanu, S., & Roncada, P. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0407-0 · Cited by 43
Wakisaka, M., Nagao, T., & Yoshinari, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151585 · Cited by 43
Osicka, T. M. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg226 · Cited by 28
Viazzi, F. C., Piscitelli, P. A., Giorda, C. B., Ceriello, A., Genovese, S., Russo, G. T., Fioretto, P., Guida, P., Cosmo, S. D., & Pontremoli, R. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.030 · Cited by 28
Microalbuminuria in primary hypertension: a guide to optimal patient management?
Viazzi, F. C., Cappadona, F., & Pontremoli, R. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0335-0 · Cited by 26
Endocannabinoids and the renal proximal tubule: An emerging role in diabetic nephropathy
Jenkin, K. A., Verty, A. N. A., McAinch, A. J., & Hryciw, D. H. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.07.008 · Cited by 24
Burling, K., Cutillas, P. R., Church, D., Lapsley, M., & Norden, A. G. W. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.11.007 · Cited by 20
Self-citationPapale, M., Paolo, S. D., Vocino, G., Rocchetti, M. T., & Gesualdo, L. (2014) · Journal of Nephrology · doi:10.1007/s40620-014-0044-5 · Cited by 18
Impaired Albumin Uptake and Processing Promote Albuminuria in OVE26 Diabetic Mice
Long, Y. S., Zheng, S., Kralik, P. M., Benz, F., & Epstein, P. N. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8749417 · Cited by 11
Cited by
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Anders, H.-J., Huber, T. B., Isermann, B., & Schiffer, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0001-y · Cited by 796
Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
Feng, X., Wang, S., Sun, Z., Dong, H., Yu, H., Huang, M., & Gao, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626390 · Cited by 321
Han, Y.-C., Tang, S.-Q., Liu, Y.-T., Li, A.-M., Zhan, M., Yang, M., Song, N., Zhang, W., Wu, X.-Q., Peng, C.-H., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04184-8 · Cited by 257
Kogot-Levin, A., Hinden, L., Riahi, Y., Israeli, T., Tirosh, B., Cerasi, E., Mizrachi, E. B., Tam, J., Mosenzon, O., & Leibowitz, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107954 · Cited by 126
Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes
Sakai, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba-Hamano, T., Minami, S., Fujimura, R., Yonishi, H., Matsuda, J., Hesaka, A., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018100983 · Cited by 96
Metadata
- Authors
- Zeni, L., Norden, A. G. W., Cancarini, G., & Unwin, R. J.
- Venue
- Journal of Nephrology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-24
- Volume
- 30
- Issue
- 6
- Pages
- 701-717
- ISSN
- 1121-8428 (ISSN-L)
- 1724-6059
- OpenAlex
- W2745568596
- Cited by
- 255
- References
- 78
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.